Effects of spirulina platensis on lipid peroxidation, antioxidant defenses, and tissue damage in kidney of alloxan-induced diabetic rats

Applied Physiology, Nutrition and Metabolism

Volumn 43, Issue 4, 2018, Pages 345-354

  Gargouri, Manel ^a,b   Hamed, Houda ^a   Akrouti, Amel ^a   Dauvergne, Xavier ^b   Magné, Christian ^b   El Feki, Abdelfattah ^a  

^a Faculté des Sciences de Sfax   (Tunisia)

^b University of Western Brittany   (France)

Author keywords

Algal diet; Antidiabetic; Diabetes mellitus; Nephropathy; Oxidative stress; Spirulina

Indexed keywords

ALLOXAN; ANTIDIABETIC AGENT; ANTIOXIDANT; INSULIN; LIPID; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL; ANIMAL FOOD; BLOOD; CHEMICALLY INDUCED; COMPARATIVE STUDY; DIABETIC NEPHROPATHY; DIET THERAPY; DIETARY SUPPLEMENT; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; KIDNEY; LIPID PEROXIDATION; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PROTEIN CARBONYLATION; SPIRULINA; TIME FACTOR; WISTAR RAT;

ALLOXAN; ANIMAL FEED; ANIMAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DIETARY SUPPLEMENTS; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY; LIPID PEROXIDATION; LIPIDS; MALE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS, WISTAR; SPIRULINA; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS;

EID: 85042132471     PISSN: 17155312     EISSN: 17155320     Source Type: Journal    
DOI: 10.1139/apnm-2017-0461     Document Type: Article

References (62)

1. Abdel-Daim, M.M., Abuzead, S.M., and Halawa, S.M. 2013. Protective role of Spirulina platensis against acute deltamethrin-induced toxicity in rats. PLoS ONE, 8(9): e72991. doi:10.1371/journal.pone.0072991. PMID:24039839.
2. Adeshara, K.A., and Diwan, A.G. 2016. Diabetes and complications: cellular signaling pathways, current understanding and targeted therapies. Curr. Drug Targets, 17(11): 1309–1328. doi:10.2174/1389450117666151209124007. PMID:26648059.
3. Aebi, H. 1984. Catalase in vitro. Methods Enzymol. 105: 121–126. doi:10.1016/S0076-6879(84)05016-3. PMID:6727660.
4. Almdal, T.P., and Vilstrup, H. 1988. Strict insulin treatment normalizes the organic nitrogen contents and the capacity of ura-N synthesis in experimental diabetes in rats. Diabetologia, 31(2): 114–118. doi:10.1007/BF00395558. PMID:3282951.
5. Alvarez-Lario, B., and Macarron-Vicente, J. 2010. Uric acid and evolution. Rheumatology, 49(11): 2010–2015. doi:10.1093/rheumatology/keq204. PMID:20627967.
6. Ankur, R., and Shahjad, A. 2012. Alloxan induced diabetes: mechanisms and effects. Int. J. Pharm. Biomed. Res. 3(2): 819–821.
7. Avdagic, N., Cosovic, E., Nakas-Icindic, E., Mornjakovic, Z., Zaciragic, A., and Hadzović-Dzuvo, A. 2008. Spirulina platensis protects against renal injury in rats with gentamicin induced acute tubular necrosis. Bosn. J. Basic Med. Sci. 8(4): 331–336. PMID:19125703.
8. Balakumar, P., Chakkarwar, V.A., and Singh, M. 2009. Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat. Mol. Cell. Biochem. 320: 149–162. doi:10.1007/s11010-008-9917-z. PMID:18830571.
9. Barnett, A. 2006. Prevention of loss of renal function over time in patients with diabetic nephropathy. Am. J. Med. 119(5): S40–S47. doi:10.1016/j.amjmed.2006.01.013. PMID:16563947.
10. Baynes, J.W., and Thorpe, S.R. 1999. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes, 48(1): 1–9. doi:10.2337/diabetes.48.1.1. PMID:9892215.
11. Beauchamp, C., and Fridovich, I. 1971. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal. Biochem. 44(1): 276–287. doi:10.1016/0003-2697(71)90370-8. PMID:4943714.
12. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248–254. doi:10.1016/0003-2697(76)90527-3. PMID:942051.
13. Council of European Communities. 1986. Council instructions about the protection of living animals used in scientific investigations. O. J. Eur. Comm. (JO 86/609/CEE), L358: 1–18.
14. Flohe, L., and Gunzler, W.A. 1984. Assays of glutathione peroxidase. Methods. Enzymol. 105: 114–121. doi:10.1016/S0076-6879(84)05015-1. PMID:6727659.
15. Friedewald, W.T., Levy, R.T., and Fredrickson, D.S. 1972. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18(6): 499–502. PMID:4337382.
16. Gabe, M. 1968. Techniques histologiques. Masson, Paris.
17. Gargouri, M., Ghorbel-Koubaa, F., Bonenfant-Magné, M., Magné, C., Dauvergne, X., Ksouri, R., et al. 2012. Spirulina or dandelion-enriched diet of mothers alleviates lead-induced damages in brain and cerebellum of newborn rats. Food Chem. Toxicol. 50(7): 2303–2310. doi:10.1016/j.fct.2012.04.003. PMID:22504531.
18. Gargouri, M., Magné, C., and El Feki, A. 2016. Hyperglycemia, oxidative stress, liver damage and dysfunction in alloxan-induced diabetic rat are prevented by Spirulina supplementation. Nutr. Res. 36(11): 1255–1268. doi:10.1016/j.nutres.2016.09.011. PMID:27865613.
19. Gökce, G., and Haznedaroglu, M.Z. 2008. Evaluation of antidiabetic, antioxidant and vasoprotective effects of Posidonia oceanica extract. J. Ethnopharmacol. 115(1): 122–130. doi:10.1016/j.jep.2007.09.016. PMID:17977678.
20. Hosseini, S.M., Khosravi-Darani, K., and Mozafari, M.R. 2013. Nutritional and medical applications of spirulina microalgae. Mini-Rev. Med. Chem. 13: 1231-1237. doi:10.2174/1389557511313080009. PMID:23544470.
21. Jiang, Z.Y., Hunt, J.V., and Wolff, S.P. 1992. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal. Biochem. 202(2): 384–389. doi:10.1016/0003-2697(92)90122-N. PMID:1519766.
22. Joventino, I.P., Alves, H.G., Neves, L.C., Pinheiro-Joventino, F., Leal, L.K., Neves, S.A., et al. 2012. The microalga Spirulina platensis presents antiinflammatory action as well as hypoglycemic and hypolipidemic properties in diabetic rats. J. Comp. Integr. Med. 9: 17. doi:10.1515/1553-3840.1534. PMID:22944720.
23. Kar, D.M., Maharana, L., Pattnaik, S., and Dash, G.K. 2006. Studies on hypoglycemic activity of Solanum xanthocarpum Schard and Wendl. fruit extract in rats. J. Ethnopharmacol. 108(2): 251–256. doi:10.1016/j.jep.2006.05.016. PMID:16829003.
24. Karadeniz, A., Cemek, M., and Simsek, N. 2009. The effects of Panax ginseng and Spirulina platensis on hepatotoxicity induced by cadmium in rats. Ecotoxicol. Environ. Safe. 72(1): 231–235. doi:10.1016/j.ecoenv.2008.02.021. PMID:18395256.
25. Kavishankar, G.B., Moree, S.S., and Lakshmidevi, N. 2014. Hepatoprotective and antioxidant activity of N-Trisaccharide in different experimental rats. Phytomedicine, 21(8–9): 1026–1031. doi:10.1016/j.phymed.2014.04.033. PMID:24867503.
26. Kayali, R., Cakatay, U., Akcay, T., and Altug, T. 2006. Effect of alpha-lipoic acid supplementation on markers of protein oxidation in post-mitotic tissues of ageing rat. Cell. Biochem. Funct. 24(1): 79–85. doi:10.1002/cbf.1190. PMID:15532093.
27. Khan, M., Shobha, J.C., Mohan, I.K., Rao Naidu, M.U., Prayag, A., and Kutala, V.K. 2006. Spirulina attenuates cyclosporine-induced nephrotoxicity in rats. J. Appl. Toxicol. 26(5): 444–451. doi:10.1002/jat.1159. PMID:16858688.
28. Layam, A., and Reddy, C.L.K. 2006. Antidiabetic property of spirulina. Diabet. Croat. 35(2): 29–33.
29. Lee, S.H., Han, J.S., Heo, S.J., Hwang, J.Y., and Jeon, Y.J. 2010. Protective effects of dieckol isolated from Ecklonia cava against high glucose-induced oxidative stress in human umbilical vein endothelial cells. Toxicol. In Vitro, 24(2): 375–381. doi:10.1016/j.tiv.2009.11.002. PMID:19896528.
30. Makni, M., Fetoui, H., Gargouri, N.K., El Garoui, M., and Zeghal, N. 2011. Antidiabetic effect of flax and pumpkin seed mixture powder: effect on hyperlipidemia and antioxidant status in alloxan diabetic rats. J. Diabetes Complicat. 25(5): 339–345. doi:10.1016/j.jdiacomp.2010.09.001. PMID:21106396.
31. Maritim, A.C., Sanders, R.A., and Watkins, J.B. 2003. Diabetes, oxidative stress and antioxidants. A review. J. Biochem. Mol. Toxicol. 17(1): 24–38. doi:10.1002/jbt.10058. PMID:12616644.
32. Matteucci, E., and Giampietro, O. 2008. Proposal open for discussion: defining agreed diagnostic procedures in experimental diabetes research. J. Ethnopharmacol. 115(2): 163–172. doi:10.1016/j.jep.2007.08.040. PMID:17961942.
33. Memişoğullari, R., and Bakan, E. 2004. Levels of ceruloplasmin, transferin, and lipid peroxidation in the serum of patients with type 2 diabetes mellitus. J. Diabetes Compl. 18(4): 193–197. doi:10.1016/S1056-8727(03)00032-1. PMID:15207835.
34. Metodiewa, D., Jaiswal, A.K., Cenas, N., Dickancaité, E., and Segura-Aguilar, J. 1999. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic. Biol. Med. 26(1–2): 107–116. doi:10.1016/S0891-5849(98)00167-1. PMID:9890646.
35. Mohan, I.K., Khan, M., Shobha, J.C., Naidu, M.U., Prayag, A., Kuppusamy, P., and Kutala, V.K. 2006. Protection against cisplatin-induced nephrotoxicity by Spirulina in rats. Cancer. Chemother. Pharmacol. 58(6): 802–808. doi:10.1007/s00280-006-0231-8. PMID:16552571.
36. Murray, M., and Pizzorno, J. 1997. Encyclopedia of Natural Medicine. 2nd ed. Prima Health Publishing, Rockling, Calif., USA.
37. Nwosu, F., Morris, J., Lund, V.A., Stewart, D., Ross, H.A., and McDougall, G.J. 2011. Anti-proliferative and potential anti-diabetic effects of phenolic-rich extracts from edible marine algae. Food Chem. 126(3): 1006–1012. doi:10.1016/j.foodchem.2010.11.111.
38. Obrosova, I.G., Fathallah, L., Liu, E., and Nourooz-Zadeh, J. 2003. Early oxidative stress in the diabetic kidney effect of DL-α-lipoic acid. Free Radic. Biol. Med. 34(2): 186–195. doi:10.1016/S0891-5849(02)01195-4. PMID:12521600.
39. Pahan, K. 2006. Lipid-lowering drugs. Cell. Mol. Life Sci. 63(10): 1165–1178. doi: 10.1007/s00018-005-5406-7. PMID:16568248.
40. Palanduz, S., Ademoglu, E., Gokkusu, C., and Tamer, S. 2001. Plasma antioxidants and type 2 diabetes mellitus. Res. Commun. Mol. Pathol. Pharmacol. 109(5–6): 309–318. PMID:12889514.
41. Pari, L., and Latha, M. 2004. Protective role of Scoparia dulcis plant extract on brain antioxidant status and lipidperoxidation in STZ diabetic male Wistar rats. BMC Complement. Altern. Med. 4: 16–24. doi:10.1186/1472-6882-4-16. PMID:15522116.
42. Parikh, P.M., Mani, U., and Iyer, U.M. 2001. Role of spirulina in the control of glycemia and lipidemia in type 2 diabetes mellitus. J. Med. Food. 4(4): 193–199. doi:10.1089/10966200152744463. PMID:12639401.
43. Pennell, J.P., Millard, M.M., and Ashby, M.H. 1981. Proteinuria in the acutely diabetic rat and its response to insulin treatment. Diabetologia, 21(1): 54–57. doi:10.1007/BF03216225. PMID:7024030.
44. Punitha, I.S.R., Rajendran, K., Shirwaikar, A., and Shirwaikar, A. 2005. Alcoholic stem extract of Coscinium fenestratum regulates carbohydrate metabolism and improves antioxidant status in streptozotocin–nicotinamide induced diabetic rats. Evid.-Based Compl. Alt. Med. 2(3): 375–381. doi:10.1093/ecam/neh099. PMID:16136216.
45. Reznick, A.Z., and Packer, L. 1994. Oxidative damage to proteins: spectrophotometric method for carbonyl. Methods Enzymol. 233: 357–359. doi:10.1016/S0076-6879(94)33041-7. PMID:8015470.
46. Rhodes, C., Stryer, L., Tasker, R., and Freeman, W.H. 1995. Biochemistry. 4th ed. San Francisco, Calif., USA. pp. 280–297.
47. Roughan, P.G. 1989. Spirulina: a source of dietary gamma-linolenic acid? J. Sci. Food. Agric. 47(1): 85–93. doi:10.1002/jsfa.2740470110.
48. Sefi, M., Fetoui, H., Soudani, N., Chtourou, Y., Makni, M., and Zeghal, N. 2012. Artemisia campestris leaf extract alleviates early diabetic nephropathy in rats by inhibiting protein oxidation and nitric oxide end products. Pathol. Res. Pract. 208(3): 157–162. doi:10.1016/j.prp.2012.01.002. PMID:22361035.
49. Senthil, N., Balu, P.M., and Murugesan, K. 2013. Antihyperglycemic effect of Spirulina, insulin and Morinda citrifolia against streptozotocin induced diabetic rat. Int. J. Curr. Microbiol. Appl. Sci. 2: 537–559.
50. Sheweita, S.A., Newairy, A.A., Mansour, H.A., and Yousef, M.I. 2002. Effect of some hypoglycemic herbs on the activity of phase I and II drug-metabolizing enzymes in alloxan-induced diabetic rats. Toxicology, 174(2): 131–139. doi:10.1016/S0300-483X(02)00048-3. PMID:11985890.
51. Soto, C.P., Presz, B.L., Favari, L.P., and Reyes, J.L. 1998. Prevention of alloxaninduced diabetes mellitus in the rat by silymarin. Comp. Biochem. Physiol. Part C Pharmacol. Toxicol. Endocrinol. 119(2): 125–129. doi:10.1016/S0742-8413(97)00198-9.
52. Tahrani, A.A., Piya, M.K., Kennedy, A., and Barnett, A.H. 2010. Glycaemic control in type 2 diabetes: targets and new therapies. Pharmacol. Ther. 125(2): 328-361. doi:10.1016/j.pharmthera.2009.11.001. PMID:19931305.
53. Tootian Louei, Z., Monfared, A., Fazelipour, S., Shybani, M.T., Rouhollah, F., Sasani, F., and Molaemi, E. 2012. Biochemical and structural changes of the kidney in mice exposed to phenol. Turk. J. Med. Sci. 42(4): 695–703. doi:10.3906/sag-1012-1332.
54. Torres-Durán, P.V., Ferreira-Hermosillo, A., and Juárez-Oropeza, M.A. 2007. Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population: a preliminary report. Lipids Health Dis. 6: 33. doi:10.1186/1476-511X-6-33. PMID:18039384.
55. Upasani, C.D., and Balaraman, R. 2003. Protective effect of Spirulina on lead induced deleterious changes in the lipid peroxidation and endogenous antioxidants in rats. Phytother. Res. 17(4): 330–334. doi:10.1002/ptr.1135. PMID:12722134.
56. Uzun, H., Konukoglu, D., Gelisgen, R., Zengin, K., and Taskin, M. 2007. Plasma protein carbonyl and thiol stress before and after laparoscopic gastric banding in morbidly obese patients. Obes. Surg. 17(10): 1367–1373. doi:10.1007/s11695-007-9242-8. PMID:18000722.
57. Vinothiya, K., and Ashokkumar, N. 2017. Modulatory effect of vanillic acid on antioxidant status in high fat diet-induced changes in diabetic hypertensive rats. Biomed. Pharmacother. 87: 640–652. doi:10.1016/j.biopha.2016.12.134. PMID:28088113.
58. Yagi, K. 1976. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med. 15(2): 212–216. doi:10.1016/0006-2944(76)90049-1. PMID:962904.
59. Yilmaz, H.R., Uz, E., Yucel, N., Altuntas, I., and Ozcelik, N. 2004. Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver. J. Biochem. Mol. Toxicol. 18(4): 234–238. doi:10.1002/jbt.20028. PMID:15452882.
60. Zanatta, L., de Sousa, E., Cazarolli, L.H., Junior, A.C., Pizzolatti, M.G., Szpoganicz, B., and Barreto Silva, F.R.M. 2007. Effect of crude extract and fractions from Vitex megapotamica leaves on hyperglycemia in alloxandiabetic rats. J. Ethnopharmacol. 109(1): 151–155. doi:10.1016/j.jep.2006.07.019. PMID:16930892.
61. Zatz, R., and Brenner, B.M. 1986. Pathogenesis of diabetic microangiopathy. The hemodynamic view. Am. J. Med. 80(3): 443–453. PMID:3513561.
62. Zhang, J., Tiller, C., Shen, J., Wang, C., Girouard, G.S., Dennis, D., Barrow, C.J., Miao, M., and Ewart, H.S. 2007. Antidiabetic properties of polysaccharideand polyphenolic-enriched fractions from the brown seaweed Ascophyllum nodosum. Can. J. Physiol. Pharmacol. 85(11): 1116–1123. doi:10.1139/Y07-105. PMID:18066114.